ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Net other income and expenses outside core operations
Percentile
P75
Within normal range
vs 2Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.23M | -18.8% |
| 2024 | $13.82M | +162.9% |
| 2023 | $5.26M | - |
| 2022 | $0.00 | +100.0% |
| 2021 | $-42.91M | - |